1 / 7

Embolic Protection Devices Market Size | Industry Report, 2018-2026

Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion, Proximal Occlusion Systems), By Application (CVDs, Neurovascular Diseases), And Segment Forecasts, 2018 - 2026

Marsh
Download Presentation

Embolic Protection Devices Market Size | Industry Report, 2018-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Embolic Protection Devices Market Analysis, Size, Growth, Share & Forecast to 2026 | Grand View Research Inc. “Embolic Protection Devices Market Size Worth $1.7 Billion by 2026” The global Embolic Protection Devices Market size is expected to reach USD 1.7 billion by 2026, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 8.4% during the forecast period. Rising incidences of cardiovascular and neurovascular diseases and growing adoption of minimally invasive diseases are propelling the market growth. Rising demand for technologically advanced embolic devices and increasing healthcare expenditure, resulting in huge funding and investments from multinational companies, are fueling the R&D in the global medical devices industry. This factor is also contributing toward the market growth. On the other hand, the product failures and recalls may limit the market growth. Low reimbursement for stenting and presence of alternative treatment methods, such as the use of drugs, may also imped the market development. However, factors such as a rise in the number of Trans-catheter Aortic Valve Replacement (TAVR) procedures will support the market expansion. The number of TAVR centers in U.S. has increased from 156 in 2012 to 511 in 2017, and approximately 35,000 patients underwent TAVR in 2016 in U.S. alone. The distal occlusion systems segment is expected to register the highest CAGR over the forecast period. Further key findings from the study suggest: Distal filter devices segment emerged as the largest segment owing to high demand for these devices • Neurovascular diseases accounted for the largest share in the application segment owing to the rising cases of neurological disorders • North America led the global embolic protection devices market with the largest share in 2017 and is likely to maintain this trend over the estimated period • Follow Us:

  2. Growing adoption of minimally invasive surgeries and increasing demand for novel technologies are facilitating the dominance of this region • The industry in the Asia Pacific is projected to witness swift growth during the forecast period owing to rapidly improving healthcare infrastructure and large target population base • Some of the key companies include Boston Scientific Corp.; Edward Lifesciences; Abbott Laboratories; Medtronic Plc; Cardinal Health, Inc.; Claret Medical, Inc.; and Innovative Cardiovascular Solutions, LLC • Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/embolic-protection- devices-market Grand View Research has segmented the global embolic protection devices market on the basis of product, application, and region: Embolic Protection Devices Product Outlook (Revenue, USD Million, 2014 - 2026) Distal Occlusion Devices • Proximal Occlusion Devices • Distal Filters • Embolic Protection Devices Application Outlook (Revenue, USD Million, 2014 - 2026) Neurovascular Diseases • Cardiovascular Diseases • Peripheral Vascular Diseases • Embolic Protection Devices Regional Outlook (Revenue, USD Million, 2014 - 2026) North America • oU.S. oCanada Europe • oU.K. oGermany Asia Pacific • oJapan oChina Follow Us:

  3. Latin America • oBrazil oMexico Middle East & Africa • oSouth Africa oSaudi Arabia Table of Content Chapter 1 Research Methodology 1.1 Information Procurement 1.2 Data Analysis 1.3 Approaches For Market Estimation 1.3.1 Approach 1: Demand analysis & bottom up approach 1.3.2 Approach 2: Top down market estimation 1.3.3 Approach 3: Commodity flow and bottom up market estimation 1.3.4 Approach 4: KoL perspective based market sizing Chapter 2 Executive Summary 2.1 Market Snapshot 2.2 Primary Data Analysis Chapter 3 Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.2 Market Driver Analysis 3.2.1 Increase in prevalence of cardiovascular, neurovascular and peripheral vascular diseases 3.2.2 Technological advancements 3.2.3 Adoption of minimally invasive surgeries 3.3 Market Restraint Analysis 3.3.1 Product recalls 3.3.2 High cost of embolic protection devices 3.4 Penetration & Growth Prospect Mapping 3.5 Embolic Protection Devices Market - Swot Analysis, By Factor (Political & Legal, Economic And Technological) 3.6 Industry Analysis - Porter’s Follow Us:

  4. 3.6.1 Threat of new entrants 3.6.2 Competitive rivalry 3.6.3 Bargaining power of suppliers 3.6.4 Bargaining power of buyers 3.6.5 Threat of substitutes Chapter 4 Embolic Protection Devices Market: Product Estimates & Trend Analysis 4.1 Embolic Protection Devices Market: Product Movement Analysis 4.2 Distal Occlusion Devices 4.2.1 Distal occlusion devices market estimates and forecasts, 2014 - 2026 (USD Million) 4.3 Proximal Occlusion Devices 4.3.1 Proximal occlusion devices market estimates and forecasts, 2014 - 2026 (USD Million) 4.4 Distal Filters 4.4.1 Distal Filters market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 5 Embolic Protection Devices Market: By Application Estimates & Trend Analysis 5.1 Embolic Protection Devices Market: Application Movement Analysis 5.2 Neurovascular Diseases 5.2.1 Neurovascular diseases market estimates and forecasts, 2014 - 2026 (USD Million) 5.3 Cardiovascular Diseases 5.3.1. Cardiovascular diseases market estimates and forecasts, 2014 - 2026 (USD Million) 5.4 Peripheral Vascular Diseases 5.4.1 Peripheral vascular diseases market estimates and forecasts, 2014 - 2026 (USD Million) Chapter 6 Embolic Protection Devices Market: Regional Estimates & Trend Analysis 6.1 Embolic Protection Devices Market: Regional Movement Analysis 6.2 North America 6.2.1 North America market estimates and forecasts, 2014 - 2026 (USD Million) 6.2.2 U.S. 6.2.2.1 U.S. market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.2.2.2 U.S. market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.2.3 Canada 6.2.3.1 Canada market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.2.3.2 Canada market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.3 Europe 6.3.1 Europe, 2014 - 2026 (USD Million) 6.3.2 U.K. Follow Us:

  5. 6.3.2.1 U.K. market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.3.2.2 U.K. market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.3.3 Germany 6.3.3.1 Germany market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.3.3.2 Germany market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.4 Asia Pacific 6.4.1 Asia Pacific, 2014 - 2026 (USD Million) 6.4.2 Japan 6.4.2.1 Japan market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.4.2.1 Japan market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.4.3 China 6.4.3.1 China market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.4.3.2 China market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.5 Latin America 6.5.1 Latin America, 2014 - 2026 (USD Million) 6.5.2 Brazil 6.5.2.1 Brazil market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.5.2.2 Brazil market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.5.3 Mexico 6.5.3.1 Mexico market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.5.3.1 Mexico market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.6 Middle East and Africa (MEA) 6.6.1 MEA, 2014 - 2025 (USD Million) 6.6.2 South Africa 6.6.2.1 South Africa market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.6.2.2 South Africa market estimates & forecasts, by application, 2014 - 2026 (USD Million) 6.6.3 Saudi Arabia 6.6.3.1 Saudi Arabia market estimates & forecasts, by product, 2014 - 2026 (USD Million) 6.6.3.1 Saudi Arabia market estimates & forecasts, by application, 2014 - 2026 (USD Million) Chapter 7 Competitive Landscape 7.1 Company Profiles 7.1.1 Abott Laboratories 7.1.1.1 Company overview 7.1.1.2 Financial performance Follow Us:

  6. 7.1.1.3 Product benchmarking 7.1.1.4 Strategic initiatives 7.1.2 Medtronic Plc. 7.1.2.1 Company overview 7.1.2.2 Financial performance 7.1.2.3 Product benchmarking 7.1.2.4 Strategic initiatives 7.1.3 Boston Scientific Inc. 7.1.3.1 Company overview 7.1.3.2 Financial performance 7.1.3.3 Product benchmarking 7.1.3.4 Strategic initiatives 7.1.4 Edward Lifesciences 7.1.4.1 Company overview 7.1.4.2 Financial performance 7.1.4.3 Product benchmarking 7.1.4.4 Strategic initiatives 7.1.5 Gore Medical 7.1.1.1 Company overview 7.1.1.2 Financial performance 7.1.1.3 Product benchmarking 7.1.1.4 Strategic initiatives 7.1.6 Innovative Cardiovascular Solutions 7.1.2.1 Company overview 7.1.2.2 Financial performance 7.1.2.3 Product benchmarking 7.1.2.4 Strategic initiatives 7.1.7 Cardinal Health 7.1.2.1 Company overview 7.1.2.2 Financial performance 7.1.2.3 Product benchmarking 7.1.2.4 Strategic initiatives 7.1.8 Transverse Medical 7.1.2.1 Company overview Follow Us:

  7. 7.1.2.2 Financial performance 7.1.2.3 Product benchmarking 7.1.2.4 Strategic initiatives 7.1.9 Allium Medical 7.1.2.1 Company overview 7.1.2.2 Financial performance 7.1.2.3 Product benchmarking 7.1.2.4 Strategic initiatives 7.1.10 Claret Medical 7.1.2.1 Company overview 7.1.2.2 Financial performance 7.1.2.3 Product benchmarking 7.1.2.4 Strategic initiatives About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related